Company intelligence / Profile preview

Zhejiang Jinhua Yinhe Biotechnology

Jinhua, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Zhejiang Jinhua Yinhe Biotechnology is a Chinese biotechnology company specializing in the research, development, and manufacturing of veterinary biological products. As a subsidiary of Yinhe Biomedical, the company is a designated manufacturer for the Ministry of Agriculture, focusing primarily on animal disease prevention. Its flagship product is the Brucella vaccine (Live, Strain S2), which is widely used in China's national animal disease control programs. The company operates large-scale GMP-certified manufacturing facilities for veterinary biologics and diagnostic reagents.

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologic
Industry: Veterinary

Partnerships

Ministry of Agriculture and Rural Affairs of the People's Republic of China

Beyond the preview

Go deeper on Zhejiang Jinhua Yinhe Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhejiang Jinhua Yinhe Biotechnology.

Explore the full profile